|Last Update: 06/18/13 - 4:00 PM EDT|
|YTD Performance: 10.39%|
|Previous Close: $10.94|
|52 Week Range: $7.71 - $11.81|
|Oustanding Shares: 241,224,839|
|Market Cap: 2,646,236,484|
|Qtr (06/13)||Qtr (09/13)||FY (12/13)||FY (12/14)|
|Number of Analysts||15||14||15||15|
|Growth Rate (Year over Year)||138.27%||21.43%||809.09%||14.79%|
Shares of FHN were downgraded to Equal-weight, said Morgan Stanley. Tere is limited near-term upside as the stock has outperformed its peers since Q2 of 2012.
Jim Cramer and Stephanie Link, co-portfolio managers of Action Alerts Plus, say if you believe the yield curve will get steeper, buy the banks.
Don’t take your cues from the so-called action.
FHN was upgraded from Sell to Neutral, Compass Point said. $10 price target. Stock is already pricing in expected net interest margin compression.
We are about to see real lending in this country.
Here are the first four areas out of 10 that should continue to flourish this year.
FHN was downgraded from Neutral to Sell, Compass Point said. Valuation call, based on a $9 price target.
Shares of FHN now seen reaching $11, according to Sterne Agee. Estimates also raised, as the company is improving efficiency. Neutral rating.
FHN was downgraded to Neutral, Guggenheim said. Valuation call, as the stock is up 10% since May.
Shares of FHN now seen reaching $9.50, Jefferies said. Estimates also raised on expense saves. Hold rating.